We are live on ! Find out more
PTC

Philadelphia Trust Company Portfolio holdings

AUM $1.42B
1-Year Est. Return 43.77%
This Fund
S&P 500
This Quarter Est. Return
+10.08%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.45B
AUM Growth
+$150M
Cap. Flow
+$33.3M
Cap. Flow %
2.3%
Top 10 Hldgs %
31.97%
Holding
239
New
25
Increased
56
Reduced
99
Closed
14

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$12.7M
2
KYNB
Kyntra Bio
KYNB
+$7.58M
3
AYX
Alteryx Inc
AYX
+$6.92M
4
ASO icon
Academy Sports + Outdoors
ASO
+$4.44M
5
NWL icon
Newell Brands
NWL
+$3.65M

Sector Composition

Rank Sector Weight
1 Technology 26.92%
2 Healthcare 18.54%
3 Communication Services 13.54%
4 Financials 12.39%
5 Industrials 10.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
51
PayPal
PYPL
$50.5B
$7.56M 0.52%
25,944
-150
-0.6% -$39.6K
GAB icon
52
Gabelli Equity Trust
GAB
$1.79B
$7.34M 0.51%
1,064,309
-24,735
-2% -$173K
ILMN icon
53
Illumina
ILMN
$28.4B
$7.1M 0.49%
15,425
+72
+0.5% +$29K
RPRX icon
54
Royalty Pharma
RPRX
$25.3B
$7.09M 0.49%
173,025
+550
+0.3% +$23.4K
SWKS icon
55
Skyworks Solutions
SWKS
$10.6B
$6.9M 0.48%
+36,000
New +$6.39M
GAP
56
The Gap Inc
GAP
$7.37B
$6.64M 0.46%
+197,385
New +$6.52M
ELAN icon
57
Elanco Animal Health
ELAN
$11.1B
$6.48M 0.45%
186,785
+1,700
+0.9% +$56.1K
LOCO icon
58
El Pollo Loco
LOCO
$462M
$6.42M 0.44%
351,227
+17,375
+5% +$297K
DGICA icon
59
Donegal Group Class A
DGICA
$714M
$5.68M 0.39%
389,850
-15,200
-4% -$232K
TENB icon
60
Tenable Holdings
TENB
$4.01B
$5.55M 0.38%
134,125
-2,350
-2% -$95.3K
SABR icon
61
Sabre
SABR
$835M
$5.52M 0.38%
442,240
-20,889
-5% -$294K
KO icon
62
Coca-Cola
KO
$375B
$5.34M 0.37%
98,718
+56,526
+134% +$3.08M
ASO icon
63
Academy Sports + Outdoors
ASO
$2.98B
$5.2M 0.36%
126,147
-126,678
-50% -$4.44M
FANG icon
64
Diamondback Energy
FANG
$52.7B
$5.01M 0.35%
53,390
+40,425
+312% +$3.33M
JNJ icon
65
Johnson & Johnson
JNJ
$625B
$4.87M 0.34%
29,571
-1,136
-4% -$188K
TJX icon
66
TJX Companies
TJX
$178B
$4.75M 0.33%
70,454
-816
-1% -$55.6K
TRIP icon
67
TripAdvisor
TRIP
$1.26B
$4.71M 0.32%
116,850
-5,125
-4% -$231K
VIG icon
68
Vanguard Dividend Appreciation ETF
VIG
$114B
$4.55M 0.31%
29,403
+2,210
+8% +$339K
MSM icon
69
MSC Industrial Direct
MSM
$6.86B
$4.49M 0.31%
+50,000
New +$4.57M
MTCH icon
70
Match Group
MTCH
$8.55B
$4.3M 0.3%
26,653
+6,179
+30% +$905K
VRTX icon
71
Vertex Pharmaceuticals
VRTX
$126B
$4.17M 0.29%
+20,695
New +$4.33M
MRK icon
72
Merck
MRK
$318B
$3.9M 0.27%
50,097
-3,559
-7% -$265K
HPE icon
73
Hewlett Packard
HPE
$70.5B
$3.79M 0.26%
+259,750
New +$4.1M
GSK icon
74
GSK
GSK
$106B
$3.69M 0.25%
74,213
-681
-0.9% -$32.7K
C icon
75
Citigroup
C
$226B
$3.62M 0.25%
51,092
-1,982
-4% -$147K

Similar funds

Philadelphia Trust Company's Q2 2021 Portfolio in Review

As of Q2 2021, Philadelphia Trust Company held 239 positions worth $1.45B, up 12% from $1.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Philadelphia Trust Company's Q2 2021 filing shows 25 new, 56 increased, 99 reduced and 14 closed positions. Its largest new stake was Citizens Financial Group: 363,420 shares worth $16.7M. The largest sale was Biogen, an estimated $12.7M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Communication Services.

  • Philadelphia Trust Company's largest Q2 2021 buy was Citizens Financial Group: 363,420 shares worth $16.7M.
  • Philadelphia Trust Company added most to Carrier Global in Q2 2021, an estimated $13.9M increase.
  • Philadelphia Trust Company's biggest Q2 2021 reduction was Biogen, cutting an estimated $12.7M.
  • Philadelphia Trust Company fully exited Kyntra Bio in Q2 2021, selling an estimated $7.58M.
  • Philadelphia Trust Company's ten largest holdings make up 32% of its $1.45B portfolio in Q2 2021.
  • Philadelphia Trust Company opened 25 new positions and closed 14 in Q2 2021.
  • Philadelphia Trust Company's portfolio value rose 12% quarter-over-quarter to $1.45B.

Based on Philadelphia Trust Company's 13F filing for Q2 2021, filed 13 Aug 2021.